Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. (Record no. 8368373)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01530 a2200385 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513074120.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199310s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0936-3076 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/BF02257674 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Heinonen, E H |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19931012 |
245 00 - TITLE STATEMENT | |
Title | Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of neural transmission. Parkinson's disease and dementia section |
Date of publication, distribution, etc. | 1993 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 193-202 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alzheimer Disease |
General subdivision | cerebrospinal fluid |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biogenic Monoamines |
General subdivision | cerebrospinal fluid |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Monoamine Oxidase Inhibitors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Norepinephrine |
General subdivision | cerebrospinal fluid |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pilot Projects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Psychiatric Status Rating Scales |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Selegiline |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tryptophan |
General subdivision | cerebrospinal fluid |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Savijärvi, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kotila, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hajba, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Scheinin, M |
773 0# - HOST ITEM ENTRY | |
Title | Journal of neural transmission. Parkinson's disease and dementia section |
Related parts | vol. 5 |
-- | no. 3 |
-- | p. 193-202 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/BF02257674">https://doi.org/10.1007/BF02257674</a> |
Public note | Available from publisher's website |
No items available.